Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:08 PM
Ignite Modification Date:
2025-12-24 @ 5:08 PM
NCT ID:
NCT01777750
Eligibility Criteria:
Inclusion Criteria:
* Age between 18 and 75 years
* Immediate transfer to cath-lab is possible
* Anterior or inferior ST-segment myocardial infarction
* ST-Segment elevation of \>0.2mV in 2 or more anatomically contiguous leads
* Duration of symptoms \<6 hours
Exclusion Criteria:
* Participation in another study
* Patients presenting with cardiac arrest/cardiogenic shock
* Tympanic temperature \<35.0°C prior to enrolment
* Thrombolytic therapy
* Previous MI
* Previous PCI or coronary artery bypass graft
* Severe heart failure at presentation (defined as a New York Heart Association (NYHA) functional class III or IV), or Killip classes II through IV
* Clinical signs of active infection
* End-stage kidney disease or hepatic failure
* Recent stroke (within the past six months)
* Conditions that may be exacerbated by hypothermia, such as haematological dyscrasias, oral anticoagulant treatment with international normalized ratio \>1.5, severe pulmonary disease
* Pregnancy
* Women of childbearing potential
* Allergy to meperidine, buspirone, magnesium, or polyvinyl chloride
* Use of a monoamine oxidase inhibitor such as selegiline in the previous 14 days
* absolute contraindications against MRI (PM, ICD, ferromagnetic implants)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT01777750
Study Brief:
Protocol Section:
NCT01777750